Designer Babies Are Here. What's the Next Edit?
By Emily Mullin,
Neo.Life/Medium
| 11. 29. 2018
A Chinese scientist engineered kids to resist HIV. Here are other changes that could be on the feature list for Humanity 2.0.
Jiankui He stunned the world this week when a report revealed he had edited genes in human embryos aiming to make people resistant to HIV infection. So far, two children, twin girls named Lulu and Nana, are said to have been born with altered genomes.
The Chinese scientist’s work crossed a line that many have feared and some have dreamed of: the creation of designer babies engineered for certain enhancements.
Editing genes in embryos is hugely controversial because the changes can be passed along to future generations. You can imagine, for instance, using gene editing to wipe out a genetic disease in an entire family tree. This is what makes altering DNA in sperm, eggs, or embryos — known as germline editing — so powerful. But if something were to go wrong, like cutting an unintended place in the genome, the resulting child could have health problems or introduce new, potentially harmful mutations into the gene pool, where they could be difficult to eradicate. That risk has made the scientific community wary of using gene editing in this way.
The floodgates are open, and...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...